Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RG0017
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RG0017 |
| Background | Tachykinin receptor 1 (TACR1) also known as neurokinin 1 receptor (NK1R) or substance P receptor (SPR) belongs to a family of proteins characterized by the interaction with G proteins. TACR1 is localized both in the central nervous system (CNS) and peripheral tissues. Tachykinin receptor 1 presents great affinity for Substance P agonist. This receptor is an interesting drug target in the studies about analgesics and antidepressants. |
| Target Gene | TACR1 |
| Gene Species | Homo sapiens (Human) |
| Abbr | HEK293-HuTACR1 |
| Alias | TACR1, NK1R, NKIR, SPR, TAC1R |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Research on the mechanisms of GPCR-related diseases |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Morphology | Epithelial |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | TACR1 tachykinin receptor 1 [ Homo sapiens ] |
| Gene Symbol | TACR1 |
| Synonyms | TACR1; tachykinin receptor 1; TAC1R; substance-P receptor; NK1R; NKIR; SPR; NK-1R; NK-1 receptor; tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor); |
| GeneID | 6869 |
| Uni ProtID | P25103 |
| Chromosome Location | 2p13.1-p12 |
| Function | G-protein coupled receptor activity; protein binding; receptor activity; signal transducer activity; substance P receptor activity; tachykinin receptor activity; |
| Pathway | Calcium signaling pathway, organism-specific biosystem; Calcium signaling pathway, conserved biosystem; Class A/1 (Rhodopsin-like receptors), organism-specific biosystem; G alpha (q) signalling events, organism-specific biosystem; GPCR downstream signaling, organism-specific biosystem; GPCR ligand binding, organism-specific biosystem; Measles, organism-specific biosystem; |
| MIM | 162323 |
A: Activation of the TACR1 receptor typically leads to an increase in intracellular calcium concentration. This can be measured and observed using calcium indicators like Fluo-4 AM.
A: Ligand-binding affinity for the TACR1 receptor can be assessed through radioligand binding assays or fluorescence polarization assays. These experiments can provide detailed information on ligand binding kinetics.
A: Activation of TACR1 can affect neurotransmitter release, which can be assessed by measuring the release of specific neurotransmitters like glutamate, GABA, etc.
A: Multiple signaling pathways, like the cAMP pathway, MAPK pathway, etc., may be activated or inhibited after TACR1 activation, which can be studied using specific pathway inhibitors or activators and subsequent molecular analyses.
A: Effective gene silencing can be achieved using siRNA specific to the TACR1 sequence, combined with an effective transfection method. Optimizing transfection conditions is crucial for enhancing silencing efficiency.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.